![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 44, 41417-41422, November 1, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Molecular Genetics, University of Illinois,
Chicago, Illinois 60607
Received for publication, April 9, 2002, and in revised form, August 9, 2002
Hepatocytes rarely proliferate in the healthy
adult liver. We explored the roles of the cyclin kinase inhibitors p21
and p27 in maintaining hepatocyte quiescence. p27 is expressed
throughout the wild-type liver, but the related protein p21 was not
detected. However, p21 was detected in livers of p27-deficient mice.
Increased p21 protein levels did not result from an increase in p21
mRNA expression, indicating that p21 expression is regulated
post-transcriptionally. p21 protein levels increased in cultured
primary hepatocytes treated with the proteasome inhibitor MG132 and
cycloheximide, indicating that p21 expression is regulated at the level
of protein stability in liver cells. Although increased expression of
cyclin-dependent kinase (Cdk) 4, Cdk2, and proliferating
cell nuclear antigen was detected in p27-deficient livers,
increased hepatocyte proliferation was detected only in livers of mice
deficient for both p21 and p27. In p27-deficient livers, p21 was found
in complexes with Cdk2 and CdK4 and can compensate for the absence of
p27. Our data indicate that cyclin kinase inhibitor activity is
important for maintaining hepatocyte quiescence in the adult liver.
Significant increases in p21 were detected in multiple tissues of
mature p27-deficient mice compared with wild-type mice, suggesting that
the ability of p21 to functionally substitute for p27 is not
liver-specific.
Cell cycle progression is regulated by
cyclin-dependent kinases
(Cdks).1 Cyclin kinase
inhibitors (CKIs), which bind and inhibit the activity of Cdks, play
key roles in negatively regulating cell proliferation. p21Waf1/Cip1 is the founding member of
the Cip/Kip family of CKIs that also includes
p27Kip1 and p57Kip2
(reviewed in Refs. 1 and 2). p21 and p27 bind and inhibit a broad range
of cyclin Cdk complexes in vitro and inhibit the cyclin A-
and cyclin E-dependent kinase Cdk2 in vivo
(reviewed in Refs. 3 and 4). p21 and p27 have also been shown to
facilitate assembly of active cyclin-Cdk complexes (5, 6). In addition to its ability to inhibit Cdk2, p21 can also bind and inhibit the
activity of proliferating cell nuclear antigen (PCNA) (reviewed in
Refs. 7 and 8).
p21 expression is induced by DNA damage and by a variety of cytokines
and growth factors, and it is often coincident with cell
differentiation (reviewed in Ref. 9). It plays an essential role in
inducing growth arrest after DNA damage (10, 11). Aging studies in
p21-deficient mice have demonstrated a role for p21 in tumor
suppression, albeit a much weaker one than that of p53 (12). Mice
lacking p21 are more susceptible to chemically induced skin carcinoma
(13, 14). In vivo, p21 seems to play roles in regulating
renewal of keratinocytes (13) and hematopoietic cells (15). Female
p21-deficient mice have decreased viability and develop a syndrome
similar to human lupus because of increased T-lymphocyte proliferation
after prolonged stimulation (16). In the kidney, p21 seems to regulate
the balance between hyperplasia and hypoplasia, and its disruption
ameliorates progression to chronic renal failure after partial
renal ablation (17). In multiple tissues and cell types, p21 is induced
after different types of challenges and seems to be a general sensor of
stress, including CCl4 toxicity in the liver (18).
Multiple functions for p27 in regulating growth and development have
been revealed in p27-deficient mice (19-21). p27-deficient mice grow
20-40% larger than wild-type littermates because of alterations in
the balance between proliferation and withdrawal from the cell cycle at
critical periods of development. These mice develop intermediate lobe
pituitary hyperplasia and adenoma, and female homozygous
p27 Adult hepatocytes are highly differentiated cells that perform a wide
variety of metabolic functions, and these cells rarely divide. Still,
they can rapidly enter the cell cycle and proliferate after tissue loss
caused by chemical or physical injury (reviewed in Refs. 29 and 30).
Both p21 and p27 have been implicated in regulation of the rapid cell
cycle progression that occurs during liver regeneration after injury
(18, 31, 32). However, a functional role for these cyclin kinase
inhibitors in maintaining quiescence of the mature hepatocyte has not
been demonstrated. We examined the expression and functions of p21 and
p27 in quiescent hepatocytes in the adult rodent liver, and we detected
aberrant hepatocyte proliferation in livers of mice deficient for both p21 and p27. Our data indicate that cyclin kinase inhibitors are required for maintaining hepatocyte quiescence even in the absence of
mitogenic signals associated with liver injury and tissue loss.
Animals--
Wild-type, p21
Mice were injected intraperitoneally with 50 µg of
5-bromo-2'-deoxyuridine (BrdUrd; Sigma) per g of body weight 2 h
before sacrifice for hepatocyte proliferation studies.
Immunoblotting and Immunoprecipitations--
In general, 50 µg
of total liver protein was separated on 12 or 15% SDS-polyacrylamide
gels and transferred to polyvinylidene difluoride membranes (Millipore,
Bedford, MA). All membranes were stained with Ponceau S to confirm
equal loading and transfer of protein. Immunoblotting was performed
using the following primary antibodies obtained from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA): p21 (SC-397), p27 (SC-528), Cdk2
(SC-163), Cdk4 (SC-260), Cdk6 (SC-177), cyclin A (SC-596), cyclin E
(SC-481), and PCNA (SC-56). Other antibodies used included cyclin D1
(MS-210; NeoMarkers, Fremont, CA) and
Immunoprecipitations were performed using the SeizeTM
primary immunoprecipitation kit (Pierce) according to the
manufacturer's instructions. 25 µg of anti-p21 antibody (PC55;
Oncogene Research Products, San Diego, CA) or anti-p27 antibody
(SC-528; Santa Cruz Biotechnology) was used for antibody coupling for
each column. Rabbit IgG was used as a control.
Culture of Primary Hepatocytes and MEFs--
Primary hepatocytes
from adult male and female mice (8-10 weeks old) were isolated by a
two-step in situ collagenase perfusion procedure as
described previously (33). Cell viability was >90% as determined by
trypan blue exclusion. After attachment, cells were maintained in
hormonally defined Williams E medium (34). One day after plating, cells
were treated with 20 µM MG132 (BIOMOL Research
Laboratories, Plymouth Meeting, PA) and/or 0.5 µg/ml cycloheximide
(Sigma). The vehicle Me2SO was added to the medium of
untreated control cells. After 5.5 h, cells were washed twice with
phosphate-buffered saline, collected in a lysis buffer, incubated for
20 min with agitation at 4 °C, and centrifuged for 10 min to collect
total cell lysates.
Mouse embryonic fibroblasts (MEFs) were prepared and cultured as
described previously (35). MEFs were serum-starved for 72 h and
then restimulated with 10% fetal bovine serum for 24 h.
Reverse Transcription-PCR--
Total liver RNA was isolated
using TRIzol reagent (Invitrogen), and cDNA was synthesized using 2 µg of total RNA with the SuperScript preamplification system
(Invitrogen) as described previously (18). For amplification of
cDNA, primers for mouse p21 (upstream primer, AGTGTGCCGTTGTCTCTTCG;
downstream primer, ACACCAGAGTGCAAGACAGC; annealing temperature
62 °C, 30 cycles; product, 311 bp) were used. Expression of mouse
S16 ribosomal protein was examined as an internal control as described
previously (18). For each combination of primers, the kinetics of PCR
amplification were studied, the number of cycles corresponding to
plateau was determined, and PCR was performed within the exponential
range. Amplified products were separated on a 2% agarose gel and
visualized with ethidium bromide staining. Quantitation was performed
using Kodak 1D image analysis software (Eastman Kodak).
Immunohistochemistry--
Liver sections were pretreated for
antigen recovery and accessibility. For the p21 and p27 antibodies,
slides were pretreated by a 5-min incubation in pepsin solution
(AutoZyme; Vector, Burlingame, CA). For BrdUrd, the best signal was
obtained after microwave heating. The PerkinElmer Life Sciences
tyramide signal amplification kit was used to amplify antibody
staining. Primary antibody sources and dilutions were anti-p21, PC55
(Oncogene Research Products), 1:150; p27, SC-528 (Santa Cruz
Biotechnology), 1:300; BrdUrd, 347583 (BD Biosciences), 1:100.
Increased p21 Expression in the p27-deficient Adult Mouse
Liver--
Expression of p21 and p27 protein was examined in livers of
wild-type, p21
p21 expression is frequently regulated at the transcriptional level
(9), so we examined levels of p21 mRNA expressed in the wild-type
and p27-deficient livers used in the immunoblotting experiments above
(Fig. 1B) using semiquantitative reverse transcription-PCR. No increase in p21 mRNA levels was detected in RNA samples from the
p27-deficient animals, compared with the wild-type animals. Expression
of the mouse S16 ribosomal protein gene was examined as a control (Fig.
1, C and D). The lack of a significant change in
p21 mRNA levels suggests that increased p21 protein expression in
the p27-deficient mouse liver is regulated at a post-transcriptional level.
To examine possible mechanisms regulating p21 protein
expression in the wild-type liver, primary hepatocytes from male and female mice were placed into culture and treated with MG132, an inhibitor of proteasome-dependent proteolysis. It has been
shown that MG132 treatment leads to stabilization of p21 protein (36) but not to an increase in p21 mRNA levels (37). An increase in p21
protein levels was detected after treatment of hepatocytes with MG132,
suggesting that p21 protein levels are regulated by proteasome-mediated
degradation in wild-type hepatocytes (Fig. 3A). To determine whether
translation of p21 transcripts contributed to the increase in p21
protein levels detected after MG132 treatment, hepatocytes were
cultured with MG132 and cycloheximide, an inhibitor of protein
synthesis. Increased p21 protein was detected in the presence of MG132
and cycloheximide providing additional support that p21 is regulated at
the level of protein stability in hepatocytes (Fig. 3, B and
C).
An increase in p21 expression has not been previously reported for
p27 p27-deficient Hepatocytes Seem Primed to Replicate, but Aberrant
Proliferation Is Not Detected in Animals with an Intact p21
Gene--
We compared baseline expression levels of a number of cell
cycle regulatory proteins including Cdk2, Cdk4, Cdk6, cyclin A, cyclin
D1, cyclin E, and PCNA in four mice of each genotype (wild-type, p21
To determine whether the increase in proliferation-associated protein
expression leads to increased cell proliferation in the normally
quiescent liver, animals were injected with BrdUrd and then
sacrificed after 2 h (Fig. 6).
Significant numbers of BrdUrd-labeled hepatocytes were detected only in
livers of mice deficient for both p21 and p27 (Fig. 6A).
Although rare proliferating cells could be detected in livers of
untreated wild-type mice and mice deficient for either p21 or p27, the
majority of these rare cells were not hepatocytes.
The total number of BrdUrd-labeled cells was counted in 30 random
fields in liver sections from each of the four genotypes (Fig.
6B). In p21/p27 p21 Associates with CyclinE/Cdk2 and Cdk4 in
p27-deficient Livers--
Expression of cyclins and Cdks was detected
in the wild-type mouse liver (Fig. 4), but hepatocyte proliferation was
detected only in the absence of both p21 and p27. We were unable to
detect consistent increases in Cdk2 activity in the whole-tissue
extracts from p21/p27-deficient livers, probably in part because the
number of proliferating cells represented only a small fraction of the total cells (data not shown). In addition, evidence suggests that p21
and p27 are also positive regulators of cyclin/Cdk complexes, facilitating their assembly (reviewed in Refs. 3 and 4). We detected
p27 in complexes with Cdk2 and Cdk4 in the livers of wild-type and
p21-deficient animals using immunoprecipitation followed by
immunoblotting (Fig. 7). In p27-deficient
mice, a significant increase in p21 protein levels was detected, and
p21 was found in complexes containing Cdk2 and Cdk4 in extracts from p27-deficient liver. Cyclin E was also detected associated with p21 in
coimmunoprecipitation experiments (data not shown). Although p21 and
p27 have been shown to play a positive role in the assembly of cyclin
D-Cdk4 complexes, association of these CKIs with Cdk2 complexes is
inhibitory and p21/p27-deficient MEFs have been shown to contain
increased levels of Cdk2 activity (6). Our data suggest that increased
levels of p21 protein in the p27-deficient liver inhibit proliferation
by inhibiting Cdk2.
Adult hepatocytes are quiescent and rarely divide under normal
conditions. We detected p27 in the nuclei of hepatocytes throughout the
adult mouse liver. We determined that p27 expression in quiescent hepatocytes is at least partially responsible for the lack of hepatocyte replication, although disruption of the p27 gene alone did
not lead to a significant increase in hepatocyte proliferation. This
was because p27-deficient hepatocytes express the related CKI p21,
which was undetectable in the wild-type liver. Many sporadically proliferating hepatocytes were detected in animals lacking both p21 and
p27, indicating that at least one of these CKIs was required for the
maintenance of mature hepatocyte quiescence. An increase in p21 was
detected in multiple tissues of mature p27-deficient mice and may
represent a general mechanism by which tissues maintain cell cycle
control in the absence of p27. We detected p21 protein in Cdk2 and Cdk4
complexes in p27-deficient livers, where it can play an active role in
the inhibition of cell cycle progression.
A number of recent reports have emphasized the importance of regulation
of p21 protein stability in growth control (38-41). Expression of p21
can be regulated by both ubiquitin-dependent and
-independent proteasomal mediated degradation (36, 42-44). We
determined that absence of p21 in wild-type liver may be attributed to
proteasomal mediated degradation in liver cells, because p21 levels
increased in hepatocytes treated with MG132 and cycloheximide. We
examined several possible mechanisms that could contribute to changes
in p21 protein turnover in the liver, including association of p21 with
CCAAT/enhancer binding protein Cooperation between CKIs has been demonstrated in various tissues. p27
and p57 have been shown to act together to control proliferation in
lens fiber cells and placental trophoblasts (48), whereas p21 and p57
play redundant functions in regulating differentiation of skeletal
muscle and lung alveoli (49). p19Ink4d and p27
cooperate to maintain quiescence of differentiated neurons (50).
Functional collaboration between p18Ink4C and
either p27 or p21 has also been demonstrated in vivo (51). p21 has been reported to be important for maintaining hematopoietic stem cell quiescence (15), although p27 is important for regulating hematopoietic progenitor cell proliferation (52). Here, we have shown
that increased p21 expression can compensate for the lack of p27 to
maintain quiescence of mature hepatocytes.
Recently, p27-deficient hepatocytes were shown to more efficiently
repopulate diseased mouse livers in transplantation studies, and it has
been suggested that p27-deficient hepatocytes may prove to be
beneficial for the treatment of human liver diseases (53, 54). Our
findings indicate that p27 is important for preventing hepatocyte
proliferation in the physiological environment of the uninjured liver
and that p21 accumulates in its absence to assume its role. As attempts
are made to generate cells useful for human hepatocyte transplantation,
it will be important to recognize that either p27 or p21 should be
expressed in hepatocytes to prevent aberrant proliferation after
repopulation of diseased liver has occurred.
Although rarely mutated in cancers, reduced expression of p27 has been
correlated with poor survival among patients with breast, prostate, or
colorectal carcinomas (reviewed in Refs. 27 and 28). Decreased
expression of p27 protein has also been associated with poor prognosis
in hepatocellular carcinomas (55-57). In mouse liver, the natural
compensatory induction of p21 expression in the liver is sufficient to
keep aberrant proliferation in check. Modulation of p27 and/or p21
expression in hepatocytes could have potential therapeutic benefits for
patients with liver cancer.
We are indebted to Dr. Andrei Gartel for
helpful discussions and Dr. Tyler Jacks for providing the p21-deficient mice.
*
This work was supported by National Institutes of Health
Grant R01-DK56283 (to A. L. T.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, August 28, 2002, DOI 10.1074/jbc.M203388200
The abbreviations used are:
Cdk, cyclin-dependent kinase;
CKI, cyclin kinase inhibitors;
PCNA, proliferating cell nuclear antigen;
MEF, mouse embryonic
fibroblast;
BrdUrd, bromodeoxyuridine.
p21 Functions to Maintain Quiescence of p27-deficient
Hepatocytes*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
mice are infertile. Although ovarian follicles
develop, they do not progress to form corpora lutea. p27 has been shown
to act as a safeguard against excessive cell proliferation after
experimental induction of inflammatory injury in the kidneys of mice
(22). p27-deficient and p27+/
mice have been shown to be
prone to tumor development in multiple tissues after
-irradiation
and other challenges (23). In general, p27 levels increase as cells
become quiescent and decrease when cells are stimulated to re-enter the
cell cycle (24-26). Post-transcriptional mechanisms are largely
responsible for regulation of p27 expression (reviewed in Refs. 27 and
28).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
,
p27
/
, and p21/p27
/
male littermates at
8-10 weeks of age were generally used for all experiments except where noted under "Results." Generation of p21
/
and
p27
/
mice was described previously (11, 19). Female
p27
/
mice are infertile. To obtain mice deficient for
both p21 and p27, p21
/
female and p27
/
male mice were crossed, resulting in offspring that were double heterozygotes, p21+/
/p27+/
. Subsequent
intercross matings between double-heterozygous male and female mice
produced offspring with the p21/p27
/
genotype.
p21
/
/p27+/
male mice were crossed with
p21
/
/p27+/
female mice to generate
additional p21/p27
/
offspring. Genomic DNA isolation
and PCR were used to confirm the genotypes of the mice. Mice were fed a
commercial diet and water ad libitum and were sacrificed in
the morning. The left lobe of the liver was fixed in 4%
paraformaldehyde and paraffin-embedded for sectioning. Other portions
of liver were frozen in liquid nitrogen and kept at
70 °C for
preparation of protein lysates and total RNA.
-actin (A-5441; Sigma).
Immunoreactive bands were detected using the SuperSignal substrate (Pierce).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
, and p27
/
male mice.
Total proteins were isolated from four or five individuals of each
genotype and subjected to immunoblotting with antibodies against p21,
p27, or
-actin. Although p27 protein expression was easily detected
in the wild-type liver (Fig.
1A), no p21 protein could be
detected, even after long exposures (Fig. 1B). However, p21
protein was detected in liver lysates prepared from p27-deficient mice
(Fig. 1B). These data were confirmed using
immunohistochemistry. p27 protein was detected in nuclei throughout
the wild-type liver lobule and in bile duct epithelial cells, whereas
no p21 expression was detected in wild-type liver samples (Fig.
2). In the p27-deficient liver, p21
protein expression was detected in hepatocyte nuclei, with highest
levels near the central veins (Fig. 2).

View larger version (38K):
[in a new window]
Fig. 1.
Expression of p21 and p27 in livers of
wild-type mice and mice deficient for p21 or p27. A,
immunoblot analyses were performed to examine p27 expression in the
livers of wild-type and p21-deficient animals. Expression of
-actin
was examined as a control. B, immunoblot analyses were
performed to examine p21 expression in livers of wild-type and
p27-deficient animals. p21 protein was detected in p27-deficient but
not wild-type liver. C, p21 mRNA expression in the liver
was examined using reverse transcription-PCR. Expression of the mouse
S16 ribosomal protein gene was examined as an internal control. A
typical ethidium bromide stained agarose gel with bands corresponding
to p21 and mouse S16 ribosomal protein RNAs from five wild-type and
five p27
/
livers is shown. D, relative
levels of p21 mRNA expressed in wild-type (WT) and
p27
/
mouse livers are shown, with the bar
representing the mean ± S.D., with levels normalized for S16
expression.

View larger version (59K):
[in a new window]
Fig. 2.
p27 and p21 protein expression and
localization in the adult mouse liver. Tyramide-amplified indirect
immunostaining was used to examine p27 and p21 expression in livers of
adult male mice. Left panel, p27 positive hepatocyte nuclei
were detected throughout the wild-type liver lobule and in bile duct
epithelium. Middle panel, p21 protein was not detected in
the wild-type liver. Right panel, p21 protein was detected
in hepatocyte nuclei in p27
/
livers. P,
portal vein; C, central vein. Scale bar, 50 µm.

View larger version (37K):
[in a new window]
Fig. 3.
Regulation of p21 expression levels by
proteasomal mediated degradation in hepatocytes. A,
primary hepatocytes were isolated from two male and three female mice,
placed in culture and treated with the proteasome inhibitor MG132.
Increased p21 levels were detected by immunoblotting after MG132
treatment.
-Actin expression was examined as a control.
B, to determine the contribution of new translation to the
increase in p21 protein levels after treatment with MG132, cultured
primary hepatocytes from three male mice were left untreated or treated
with MG132, cycloheximide (CHX), or MG132 + cycloheximide.
Increased p21 levels were detected when hepatocytes were treated with
both MG132 and cycloheximide indicating that inhibition of proteasomal
mediated degradation results in increased p21 levels in hepatocytes.
Expression of
-actin was examined as a control. C,
relative levels of p21 protein normalized to
-actin expression with
bars representing the mean ± S.D. are shown.
/
tissues or cells. We examined p21 protein levels
in serum-starved and stimulated p27
/
MEFs (Fig.
4A). We could not detect
increased p21 expression as observed in the liver, suggesting that
increased p21 expression in the absence of p27 might be liver-specific.
However, when we compared p21 protein levels in a variety of
differentiated tissues from mature (8-19 weeks of age) wild-type and
p27-deficient mice, we discovered higher levels of p21 protein in
multiple tissues of p27-deficient mice (Fig. 4B). Thus,
increased accumulation of p21 may be important for cell cycle control
in multiple tissues of the p27-deficient mouse.

View larger version (44K):
[in a new window]
Fig. 4.
p21 expression in p27-deficient mouse
embryonic fibroblasts and tissues. A, expression of
p21, PCNA, and
-actin were examined in wild-type (WT) and
p27-deficient mouse embryonic fibroblasts and liver extracts by
immunoblotting. Increased p21 levels were detected in the p27-deficient
liver extract, but not in serum-starved (0 h) or stimulated (24 h)
p27-deficient MEFs. A longer exposure was required to detect p21 in
liver tissue than in MEFs. Increased levels of PCNA were also detected
in the p27-deficient liver. B, protein lysates were prepared
from differentiated tissues of wild-type and p27-deficient mice, and
p21 levels were compared by immunoblotting. Increased p21 protein
levels were detected in multiple tissues of mature p27
/
mice. Expression of p27 and
-actin expression were examined as
controls. Membranes were also stained to confirm equal loading of
protein as the
-actin antibody does not recognize adult cardiac
actin.
/
, p27
/
, and
p21/p27
/
) (Fig. 5).
-Actin expression levels were examined as a control for protein
loading. Increased expression of cyclin A was detected in all animals
deficient for either p21 or p27. Increases in Cdk2 and PCNA expression
were also apparent in livers of p27
/
and p21/p27
/
mice. Increased expression of
proliferation-associated proteins suggested that there might be an
increase in hepatic proliferation in mice lacking p27.

View larger version (66K):
[in a new window]
Fig. 5.
Increased expression of
proliferation-associated proteins in the livers of p21- and
p27-deficient mice. Expression of proliferation-associated
proteins Cdk2, Cdk4, Cdk6, cyclin A, cyclin D1, cyclin E, PCNA, and
-actin was examined using immunoblotting and extracts from four mice
of each genotype (wild type, p21
/
,
p27
/
, and p21/p27
/
). Reproducible
increases in Cdk2 and PCNA protein levels were detected in extracts
from livers of mice deficient for p27.

View larger version (53K):
[in a new window]
Fig. 6.
Increased proliferation in the livers of mice
lacking both p21 and p27. Animals were injected with BrdUrd and
sacrificed after 2 h. A, tyramide-amplified indirect
immunostaining of BrdUrd is shown in livers of wild-type,
p21
/
, p27
/
, and
p21/p27
/
animals. BrdUrd immunoreactivity was
detected with fluorescein isothiocyanate (white),
whereas nuclei were stained with 4,6 diamidino-2-phenylindole
(gray). Greatest numbers of replicating cells are observed
in livers of p21/p27-deficient mice (arrowheads).
B, BrdUrd-labeled cells were counted in 30 fields for each
genotype. The majority of fields counted in the p21/p27-deficient liver
sections contained two or three labeled cells, whereas no labeled cells
could be detected in most fields counted on sections from the other
three genotypes.
/
untreated livers most
fields contained two or three BrdUrd-labeled nuclei. In comparison,
most fields were negative in the other three genotypes. Similar results
were obtained in separate experiments in which untreated mice were
injected with [3H]thymidine 1 h before sacrifice
(data not shown). The few fields from p27
/
liver
sections containing more than four labeled cells contained arteries and
veins, and the majority of the labeled cells were not hepatocytes. The
increase in the number of sporadically proliferating hepatocytes in the
untreated livers of mice lacking both p21 and p27 suggests that the
increase in p21 expression detected in the untreated
p27
/
liver can compensate for the absence of p27 and
inhibit sporadic proliferation.

View larger version (64K):
[in a new window]
Fig. 7.
p21 is associated with Cdk2 and Cdk4 in the
livers of p27-deficient animals. Immunoprecipitation of p27 or p21
from wild-type (WT), p21
/
, and
p27
/
adult mouse liver extracts was followed by
immunoblotting with antibodies specific for p27, p21, Cdk2, and
Cdk4.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, and AKT activity (data not shown).
CCAAT/enhancer binding protein
can bind and regulate levels of p21
protein and is expressed at high levels in quiescent hepatocytes (45).
However, we were unable to detect differences in the expression of
CCAAT/enhancer binding protein
or association of p21 with
CCAAT/enhancer binding protein
between wild-type and
p27
/
animals. Recent reports indicate that AKT activity
may regulate p21 protein turnover (41, 46, 47), but we were unable to detect any changes in AKT activity or AKT association with p21 in
p27-deficient livers.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Molecular
Genetics, M/C 669, University of Illinois College of Medicine, 900 S. Ashland Ave., Chicago, IL 60607. Tel.: 312-996-7964; Fax: 312-413-0353; E-mail: atyner@uic.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Dotto, G. P.
(2000)
Biochim. Biophys. Acta
1471,
M43-M56[Medline]
[Order article via Infotrieve]
2.
Gartel, A. L.,
Serfas, M. S.,
and Tyner, A. L.
(1996)
Proc. Soc. Exp. Biol. Med.
213,
137-148
3.
Sherr, C. J.,
and Roberts, J. M.
(1999)
Genes Dev.
13,
1501-1512 4.
Sherr, C. J.
(2000)
Cancer Res.
60,
3689-3695 5.
LaBaer, J.,
Garrett, M. D.,
Stevenson, L. F.,
Slingerland, J. M.,
Sandhu, C.,
Chou, H. S.,
Fattaey, A.,
and Harlow, E.
(1997)
Genes Dev.
11,
847-862 6.
Cheng, M.,
Olivier, P.,
Diehl, J. A.,
Fero, M.,
Roussel, M. F.,
Roberts, J. M.,
and Sherr, C. J.
(1999)
EMBO J.
18,
1571-1583[CrossRef][Medline]
[Order article via Infotrieve]
7.
Tsurimoto, T.
(1999)
Front. Biosci.
4,
D849-D858[Medline]
[Order article via Infotrieve]
8.
Warbrick, E.
(2000)
Bioessays
22,
997-1006[CrossRef][Medline]
[Order article via Infotrieve]
9.
Gartel, A. L.,
and Tyner, A. L.
(1999)
Exp. Cell Res.
246,
280-289[CrossRef][Medline]
[Order article via Infotrieve]
10.
Deng, C.,
Zhang, P.,
Harper, J.,
Elledge, S.,
and Leder, P.
(1995)
Cell
82,
675-684[CrossRef][Medline]
[Order article via Infotrieve]
11.
Brugarolas, J.,
Chandrasekaran, C.,
Gordon, J. I.,
Beach, D.,
Jacks, T.,
and Hannon, G. J.
(1995)
Nature
377,
552-557[CrossRef][Medline]
[Order article via Infotrieve]
12.
Martin-Caballero, J.,
Flores, J. M.,
Garcia-Palencia, P.,
and Serrano, M.
(2001)
Cancer Res.
61,
6234-6238 13.
Topley, G. I.,
Okuyama, R.,
Gonzales, J. G.,
Conti, C.,
and Dotto, G. P.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9089-9094 14.
Philipp, J., Vo, K.,
Gurley, K. E.,
Seidel, K.,
and Kemp, C. J.
(1999)
Oncogene
18,
4689-4698[CrossRef][Medline]
[Order article via Infotrieve]
15.
Cheng, T.,
Rodrigues, N.,
Shen, H.,
Yang, Y.,
Dombkowski, D.,
Sykes, M.,
and Scadden, D. T.
(2000)
Science
287,
1804-1808 16.
Balomenos, D.,
Martin-Caballero, J.,
Garcia, M. I.,
Prieto, I.,
Flores, J. M.,
Serrano, M.,
and Martinez, A. C.
(2000)
Nat. Med.
6,
171-176[CrossRef][Medline]
[Order article via Infotrieve]
17.
Megyesi, J.,
Price, P. M.,
Tamayo, E.,
and Safirstein, R. L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
10830-10805 18.
Serfas, M. S.,
Goufman, E.,
Feuerman, M. H.,
Gartel, A. L.,
and Tyner, A. L.
(1997)
Cell Growth Differ.
8,
951-961[Abstract]
19.
Kiyokawa, H.,
Kineman, R. D.,
Manova-Todorova, K. O.,
Soares, V. C.,
Hoffman, E. S.,
Ono, M.,
Khanam, D.,
Hayday, A. C.,
Frohman, L. A.,
and Koff, A.
(1996)
Cell
85,
721-732[CrossRef][Medline]
[Order article via Infotrieve]
20.
Fero, M. L.,
Rivkin, M.,
Tasch, M.,
Porter, P.,
Carow, C. E.,
Firpo, E.,
Polyak, K.,
Tsai, L. H.,
Broudy, V.,
Perlmutter, R. M.,
Kaushansky, K.,
and Roberts, J. M.
(1996)
Cell
85,
733-744[CrossRef][Medline]
[Order article via Infotrieve]
21.
Nakayama, K.,
Ishida, N.,
Shirane, M.,
Inomata, A.,
Inoue, T.,
Shishido, N.,
Horii, I.,
and Loh, D. Y.
(1996)
Cell
85,
707-720[CrossRef][Medline]
[Order article via Infotrieve]
22.
Ophascharoensuk, V.,
Fero, M. L.,
Hughes, J.,
Roberts, J. M.,
and Shankland, S. J.
(1998)
Nat. Med.
4,
575-580[CrossRef][Medline]
[Order article via Infotrieve]
23.
Fero, M. L.,
Randel, E.,
Gurley, K. E.,
Roberts, J. M.,
and Kemp, C. J.
(1998)
Nature
396,
177-180[CrossRef][Medline]
[Order article via Infotrieve]
24.
Nourse, J.,
Firpo, E.,
Flanagan, W. M.,
Coat, S.,
Polyak, K.,
Lee, M. H.,
Massague, J.,
Crabtree, G. R.,
and Roberts, J. M.
(1994)
Nature
372,
570-573[CrossRef][Medline]
[Order article via Infotrieve]
25.
Coats, S.,
Flanagan, W. M.,
Nourse, J.,
and Roberts, J. M.
(1996)
Science
272,
877-880[Abstract]
26.
Rivard, N.,
L'Allemain, G.,
Bartek, J.,
and Pouyssegur, J.
(1996)
J. Biol. Chem.
271,
18337-18341 27.
Philipp-Staheli, J.,
Payne, S. R.,
and Kemp, C. J.
(2001)
Exp. Cell Res.
264,
148-168[CrossRef][Medline]
[Order article via Infotrieve]
28.
Slingerland, J.,
and Pagano, M.
(2000)
J. Cell. Physiol.
183,
10-7[CrossRef][Medline]
[Order article via Infotrieve]
29.
Fausto, N.
(2000)
J. Hepatol.
32,
19-31[Medline]
[Order article via Infotrieve]
30.
Michalopoulos, G. K.,
and DeFrances, M. C.
(1997)
Science
276,
60-68 31.
Albrecht, J. H.,
Meyer, A. H.,
and Hu, M. Y.
(1997)
Hepatology
25,
557-563[CrossRef][Medline]
[Order article via Infotrieve]
32.
Albrecht, J. H.,
Poon, R. Y.,
Ahonen, C. L.,
Rieland, B. M.,
Deng, C.,
and Crary, G. S.
(1998)
Oncogene
16,
2141-2150[CrossRef][Medline]
[Order article via Infotrieve]
33.
Hatano, E.,
Bradham, C. A.,
Stark, A.,
Iimuro, Y.,
Lemasters, J. J.,
and Brenner, D. A.
(2000)
J. Biol. Chem.
275,
11814-11823 34.
Viollet, B.,
Yaniv, M.,
and Pontoglio, M.
(2001)
Mol. Cell. Biol.
21,
3662-3670 35.
Tsutsui, T.,
Hesabi, B.,
Moons, D. S.,
Pandolfi, P. P.,
Hansel, K. S.,
Koff, A.,
and Kiyokawa, H.
(1999)
Mol. Cell. Biol.
19,
7011-7019 36.
Sheaff, R. J.,
Singer, J. D.,
Swanger, J.,
Smitherman, M.,
Roberts, J. M.,
and Clurman, B. E.
(2000)
Mol. Cell
5,
403-410[CrossRef][Medline]
[Order article via Infotrieve]
37.
Klibanov, S. A.,
O'Hagan, H. M.,
and Ljungman, M.
(2001)
J. Cell Sci.
114,
1867-1873[Abstract]
38.
Oh, H.,
Mammucari, C.,
Nenci, A.,
Cabodi, S.,
Cohen, S. N.,
and Dotto, G. P.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
5430-5435 39.
Bao, W.,
Thullberg, M.,
Zhang, H.,
Onischenko, A.,
and Stromblad, S.
(2002)
Mol. Cell. Biol.
22,
4587-4597 40.
Kim, G. Y.,
Mercer, S. E.,
Ewton, D. Z.,
Yan, Z.,
Jin, K.,
and Friedman, E.
(2002)
J. Biol. Chem.
10,
29792-29802
41.
Rossig, L.,
Badorff, C.,
Holzmann, Y.,
Zeiher, A. M.,
and Dimmeler, S.
(2002)
J. Biol. Chem.
4,
9684-9689
42.
Maki, C. G.,
and Howley, P. M.
(1997)
Mol. Cell. Biol.
17,
355-363[Abstract]
43.
Touitou, R.,
Richardson, J.,
Bose, S.,
Nakanishi, M.,
Rivett, J.,
and Allday, M. J.
(2001)
EMBO J.
20,
2367-2375[CrossRef][Medline]
[Order article via Infotrieve]
44.
Cayrol, C.,
and Ducommun, B.
(1998)
Oncogene
17,
2437-2444[CrossRef][Medline]
[Order article via Infotrieve]
45.
Timchenko, N. A.,
Harris, T. E.,
Wilde, M.,
Bilyeu, T. A.,
Burgess-Beusse, B. L.,
Finegold, M. J.,
and Darlington, G. J.
(1997)
Mol. Cell. Biol.
17,
7353-7361[Abstract]
46.
Rossig, L.,
Jadidi, A. S.,
Urbich, C.,
Badorff, C.,
Zeiher, A. M.,
and Dimmeler, S.
(2001)
Mol. Cell. Biol.
21,
5644-5657 47.
Li, Y.,
Dowbenko, D.,
and Lasky, L. A.
(2002)
J. Biol. Chem.
277,
11352-11361 48.
Zhang, P.,
Wong, C.,
DePinho, R. A.,
Harper, J. W.,
and Elledge, S. J.
(1998)
Genes Dev.
12,
3162-3167 49.
Zhang, P.,
Wong, C.,
Liu, D.,
Finegold, M.,
Harper, J. W.,
and Elledge, S. J.
(1999)
Genes Dev.
13,
213-224 50.
Zindy, F.,
Cunningham, J. J.,
Sherr, C. J.,
Jogal, S.,
Smeyne, R. J.,
and Roussel, M. F.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
13462-12367 51.
Franklin, D. S.,
Godfrey, V. L.,
O'Brien, D. A.,
Deng, C.,
and Xiong, Y.
(2000)
Mol. Cell. Biol.
20,
6147-6158 52.
Cheng, T.,
Rodrigues, N.,
Dombkowski, D.,
Stier, S.,
and Scadden, D. T.
(2000)
Nat. Med.
6,
1235-1240[CrossRef][Medline]
[Order article via Infotrieve]
53.
Karnezis, A. N.,
Dorokhov, M.,
Grompe, M.,
and Zhu, L.
(2001)
J. Clin. Invest.
108,
383-390[CrossRef][Medline]
[Order article via Infotrieve]
54.
Lee, L. A.
(2001)
J. Clin. Invest.
108,
367-369[CrossRef][Medline]
[Order article via Infotrieve]
55.
Hui, A. M.,
Sun, L.,
Kanai, Y.,
Sakamoto, M.,
and Hirohashi, S.
(1998)
Cancer Lett.
132,
67-73[CrossRef][Medline]
[Order article via Infotrieve]
56.
Ito, Y.,
Matsuura, N.,
Sakon, M.,
Miyoshi, E.,
Noda, K.,
Takeda, T.,
Umeshita, K.,
Nagano, H.,
Nakamori, S.,
Dono, K.,
Tsujimoto, M.,
Nakahara, M.,
Nakao, K.,
Taniguchi, N.,
and Monden, M.
(1999)
Hepatology
30,
90-99[CrossRef][Medline]
[Order article via Infotrieve]
57.
Tannapfel, A.,
Grund, D.,
Katalinic, A.,
Uhlmann, D.,
Kockerling, F.,
Haugwitz, U.,
Wasner, M.,
Hauss, J.,
Engeland, K.,
and Wittekind, C.
(2000)
Int. J. Cancer
89,
350-355[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Sang, H. A. Coller, and J. M. Roberts Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1 Science, August 22, 2008; 321(5892): 1095 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. James, A. Ray, D. Leznova, and S. W. Blain Differential Modification of p27Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity Mol. Cell. Biol., January 1, 2008; 28(1): 498 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Stehr, N. P. Bernal, C. R. Erwin, K. Q. Bernabe, J. Guo, and B. W. Warner Roles for p21waf1/cip1 and p27kip1 during the adaptation response to massive intestinal resection Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G933 - G941. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, A. Velcich, I. Lozonschi, J. Liang, C. Nicholas, M. Zhuang, L. Bancroft, and L. H. Augenlicht Inactivation of p21WAF1/cip1 Enhances Intestinal Tumor Formation in Muc2-/- Mice Am. J. Pathol., April 1, 2005; 166(4): 1239 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gilbert, A. Loranger, and N. Marceau Keratins Modulate c-Flip/Extracellular Signal-Regulated Kinase 1 and 2 Antiapoptotic Signaling in Simple Epithelial Cells Mol. Cell. Biol., August 15, 2004; 24(16): 7072 - 7081. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Kalinichenko, M. L. Major, X. Wang, V. Petrovic, J. Kuechle, H. M. Yoder, M. B. Dennewitz, B. Shin, A. Datta, P. Raychaudhuri, et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor Genes & Dev., April 1, 2004; 18(7): 830 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Kwon, A. Jovanovic, M. S. Serfas, and A. L. Tyner The Cdk Inhibitor p21 Is Required for Necrosis, but It Inhibits Apoptosis following Toxin-induced Liver Injury J. Biol. Chem., August 8, 2003; 278(32): 30348 - 30355. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Kim, I.-J. Kang, H. J. Cho, W. K. Kim, Y.-L. Ha, and J. H. Y. Park Conjugated Linoleic Acid Downregulates Insulin-Like Growth Factor-I Receptor Levels in HT-29 Human Colon Cancer Cells J. Nutr., August 1, 2003; 133(8): 2675 - 2681. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Cho, W. K. Kim, E. J. Kim, K. C. Jung, S. Park, H. S. Lee, A. L. Tyner, and J. H. Y. Park Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line Am J Physiol Gastrointest Liver Physiol, June 1, 2003; 284(6): G996 - G1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jirawatnotai, D. S. Moons, C. O. Stocco, R. Franks, D. B. Hales, G. Gibori, and H. Kiyokawa The Cyclin-dependent Kinase Inhibitors p27Kip1 and p21Cip1 Cooperate to Restrict Proliferative Life Span in Differentiating Ovarian Cells J. Biol. Chem., May 2, 2003; 278(19): 17021 - 17027. [Abstract] [Full Text] [PDF] |
||||
| ||||